Table 4.
2-year clinical outcomes of STEMI and UA/NSTEMI subgroups.
| STEMI | UA/NSTEMI | |||||
|---|---|---|---|---|---|---|
| LMCA (n = 24) | Non-LMCA (n = 1421) | p value | LMCA (n = 131) | Non-LMCA (n = 4853) | p value | |
| All-cause death | 3 (12.5) | 28 (3.0) | 0.013 | 1 (0.8) | 54 (1.1) | 1.000 |
| Cardiac death | 3 (12.5) | 19 (1.3) | 0.005 | 1 (0.8) | 28 (0.6) | 0.539 |
| Myocardial infarction | 4 (16.7) | 31 (2.2) | 0.002 | 7 (5.3) | 85 (1.8) | 0.010 |
| Unplanned revascularization | 1 (4.2) | 129 (9.1) | 0.717 | 9 (6.9) | 417 (8.6) | 0.487 |
| In-stent thrombosis | 3 (12.5) | 14 (1.0) | 0.002 | 4 (3.1) | 37 (0.8) | 0.022 |
| Stroke | 0 (0) | 16 (1.1) | 1.000 | 6 (4.6) | 72 (1.5) | 0.016 |
| Bleeding | 3 (12.5) | 77 (5.4) | 0.143 | 8 (6.1) | 324 (6.7) | 0.796 |
| MACCE | 6 (25.0) | 185 (13.0) | 0.118 | 18 (13.7) | 583 (12.0) | 0.549 |
STEMI = ST elevation myocardial infarction; NSTEMI = non-ST elevation myocardial infarction; UA = unstable angina; MACCE = major adverse cardiac and cerebrovascular events.